Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia

Gabriele Gugliotta, F. Castagnetti, M. Breccia, A. Gozzini, Emilio Usala, A.M. Carella, Giovanna Rege-Cambrin, B. Martino, Elisabetta Abruzzese, F. Albano, Fabio Stagno, L. Luciano, Mariella D'Adda, M. Bocchia, F. Cavazzini, M. Tiribelli, M. Lunghi, A. Pia Falcone, Caterina Musolino, G. L. LevatoC. Venturi, S. Soverini, Michele Cavo, G. Alimena, F. Pane, G. Martinelli, G. Saglio, G. Rosti, M. Baccarani

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences